nRichDX®, based in Irvine, California, provides kits and automated solutions for maximizing isolation of rare cfDNA, cfRNA, and CTCs. The patented Revolution Sample Prep System™ is engineered for liquid biopsy applications, isolating analytes from blood, plasma, urine, and other biofluids.
RichDX's Revolution Sample Prep System is the first and only high-yield, high-recovery, IVD-labeled automated sample preparation platform with the widest commercially available sample volume range. Revolution enables extraction from sample volumes as little as 1 mL to 100 mL in a single extraction using the company’s patented Revolution nRicher™ Cartridges.
Unlike other methods, Revolution sample prep doesn’t require yield-lowering manual preconcentrations, eluate pooling, sample transfers, or sample re-elution steps. nRichDX helps solve one of precision medicine’s greatest problems – inaccurate or incomplete diagnostic results for liquid biopsy-based assays due to insufficient quantity of analyte. The Revolution platform greatly enhances test sensitivity, enabling high-confidence test results that promote earlier detection, monitoring, timely treatment, and optimal patient outcomes.
